265 related articles for article (PubMed ID: 29854622)
1. What is the meaning of 'A compound is carcinogenic'?
Schrenk D
Toxicol Rep; 2018; 5():504-511. PubMed ID: 29854622
[TBL] [Abstract][Full Text] [Related]
2. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
Bolt HM; Degen GH
Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
5. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
Dieter HH
Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
[TBL] [Abstract][Full Text] [Related]
6. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
7. The influence of thresholds on the risk assessment of carcinogens in food.
Pratt I; Barlow S; Kleiner J; Larsen JC
Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
[TBL] [Abstract][Full Text] [Related]
8. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
10. Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens.
Bolt HM; Huici-Montagud A
Arch Toxicol; 2008 Jan; 82(1):61-4. PubMed ID: 18008062
[TBL] [Abstract][Full Text] [Related]
11. The causes and prevention of cancer: the role of environment.
Ames BN; Gold LS
Biotherapy; 1998; 11(2-3):205-20. PubMed ID: 9677052
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk assessment.
Clewell RA; Thompson CM; Clewell HJ
Chem Biol Interact; 2019 Mar; 301():112-127. PubMed ID: 30763550
[TBL] [Abstract][Full Text] [Related]
13. New aspects in the classification of carcinogens.
Foth H; Degen GH; Bolt HM
Arh Hig Rada Toksikol; 2005 Jun; 56(2):167-75. PubMed ID: 15968833
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
Hernández LG; van Steeg H; Luijten M; van Benthem J
Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
[TBL] [Abstract][Full Text] [Related]
15. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
16. Is current risk assessment of non-genotoxic carcinogens protective?
Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
[TBL] [Abstract][Full Text] [Related]
17. The use of dose-response data in a margin of exposure approach to carcinogenic risk assessment for genotoxic chemicals in food.
Benford DJ
Mutagenesis; 2016 May; 31(3):329-31. PubMed ID: 26297741
[TBL] [Abstract][Full Text] [Related]
18. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
Melnick RL; Kohn MC; Portier CJ
Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
20. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
Brambilla G; Martelli A
Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
